Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactur...
FDA Drug Recall #D-1499-2016 — Class II — August 3, 2016
Recall Summary
| Recall Number | D-1499-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 3, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Aurobindo Pharma USA Inc |
| Location | Plainsboro, NJ |
| Product Type | Drugs |
| Quantity | 23016 bottles |
Product Description
Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90
Reason for Recall
Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.
Distribution Pattern
CA
Lot / Code Information
PSSB16011-A, Exp 01/18
Other Recalls from Aurobindo Pharma USA Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0471-2025 | Class II | Acetaminophen Tablets, 325 mg, 100-count bottle... | May 22, 2025 |
| D-0149-2025 | Class II | Nebivolol Tablets, 2.5. mg, 30-count bottles, R... | Dec 6, 2024 |
| D-0078-2025 | Class II | Cinacalcet Tablets, 60mg, packaged in: a) 30-co... | Nov 7, 2024 |
| D-0077-2025 | Class II | Cinacalcet Tablets, 30 mg, packaged in: a) 30-c... | Nov 7, 2024 |
| D-0079-2025 | Class II | Cinacalcet Tablets, 90 mg, packaged in: a) 30-c... | Nov 7, 2024 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.